Synopsys (Synopsys) ROCE %

: 24.45% (As of Jan. 2024)

View and export this data going back to 1992. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Synopsys's annualized ROCE % for the quarter that ended in Jan. 2024 was 24.45%.

Synopsys ROCE % Historical Data

The historical data trend for Synopsys's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synopsys Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

ROCE %

12.81

12.20

13.23

17.21

18.63

Synopsys Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %																16.58	16.82	18.07	22.55	24.45

Synopsys ROCE % Calculation

Synopsys's annualized ROCE % for the fiscal year that ended in Oct. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	1302.96	/	( ( (9418.087 - 2774.499)	+	(10333.131 - 2985.451) )	/ 2 )
	=	1302.96	/	( (6643.588	+	7347.68)	/ 2 )
	=	1302.96	/	6995.634
	=	18.63 %

Synopsys's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	1865.712	/	( ( (10333.131 - 2985.451)	+	(10558.259 - 2644.507) )	/ 2 )
	=	1865.712	/	( ( 7347.68	+	7913.752 )	/ 2 )
	=	1865.712	/	7630.716
	=	24.45 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Synopsys (NAS:SNPS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Synopsys ROCE % Related Terms

Thank you for viewing the detailed overview of Synopsys's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Synopsys (Synopsys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SNPS:Mexico SYPd:UK SYP:Germany SYP:Germany SYP:Germany S1NP34:Brazil

Address

675 Almanor Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.synopsys.com

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Executives

Mercedes Johnson	director	MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Richard S. Mahoney	officer: Chief Revenue Officer	2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr	officer: General Counsel &	C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Sudhindra Kankanwadi	officer: VP and Corporate Controller	690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter	director	C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Geus Aart De	director, officer: Chairman of the Board & Co-CEO
Sassine Ghazi	officer: Chief Operating Officer	3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Shelagh Glaser	officer: CFO	ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Roy Vallee	director	2211 S 47TH ST, PHOENIX AZ 85034
Joseph W Logan	officer: EVP, Sales & Corp Marketing	700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias	director	UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham	officer: CFO	700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen	director	58 SUNSET RIDGE LANE, BOLTON MA 01740
Marc N Casper	director	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Chi-foon Chan	director, officer: Co-CEO & President